ABUS Dividend: Arbutus Biopharma Corp Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	15	6	18	39	10	6
Revenue Growth (YoY)	50%	-67%	-54%	290%	67%	0%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	18	22	22	17	17	14
Research & Development	37	54	73	84	65	47
Operating Expenses	58	78	96	104	84	64
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-54	-69	-72	-65	-76	-63
Income Tax Expense	--	0	0	4	--	0
Net Income	-54	-69	-72	-69	-88	-75
Net Income Growth	-30%	-4%	4%	-22%	17%	-54%
Shares Outstanding (Diluted)	192.39	185.6	165.96	150.94	106.24	75.84
Shares Change (YoY)	2%	12%	10%	42%	40%	33%
EPS (Diluted)	-0.28	-0.37	-0.43	-0.46	-0.83	-1
EPS Growth	-28.99%	-14%	-5%	-45%	-17%	-65%
Free Cash Flow	-60	-65	-86	-35	-68	-51
Free Cash Flow Per Share	-0.31	-0.35	-0.51	-0.23	-0.64	-0.67
Gross Margin	--	--	--	--	--	--
Operating Margin	-286.66%	-1,200%	-433.33%	-166.66%	-730%	-950%
Profit Margin	-360%	-1,150%	-400%	-176.92%	-880%	-1,250%
Free Cash Flow Margin	-400%	-1,083.33%	-477.77%	-89.74%	-680%	-850%
EBITDA	-42	-71	-77	-64	-72	-56
EBITDA Margin	-280%	-1,183.33%	-427.77%	-164.1%	-720%	-933.33%
D&A For EBITDA	1	1	1	1	1	1
EBIT	-43	-72	-78	-65	-73	-57
EBIT Margin	-286.66%	-1,200%	-433.33%	-166.66%	-730%	-950%
Effective Tax Rate	--	0%	0%	-6.15%	--	0%

Arbutus Biopharma Corp (ABUS) Price